Načítá se...
CYP51 as drug targets for fungi and protozoan parasites: past, present and future
The efficiency of treatment of human infections with the unicellular eukaryotic pathogens such as fungi and protozoa remains deeply unsatisfactory. For example, the mortality rates from nosocomial fungemia in critically ill, immunosuppressed or post cancer patients often exceed 50%. A set of six sys...
Uloženo v:
| Vydáno v: | Parasitology |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6185833/ https://ncbi.nlm.nih.gov/pubmed/29642960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S0031182018000562 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|